Vertex Pharmaceuticals Cash from Discontinued Operations Adjustment (Quarterly) Analysis

Vertex Pharmaceuticals, Inc. (VRTX)

441.36 +2.44 (+0.56%) USD | NASDAQ | Jan 16, 16:00

440.02 -1.34 (-0.30%) After-Hours: 20:00

View Cash from Discontinued Operations Adjustment (Quarterly) for VRTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Discontinued Operations Adjustment (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	--
Amgen, Inc.	--
Eli Lilly & Co.	--
Merck & Co., Inc.	--
Alnylam Pharmaceuticals, Inc.	--